The discovery of LY6E as a potential objective for cancer intervention has initiated considerable research . Several therapeutic agents are now tested with the goal of selectively neutralizing LY6E's role and inducing an anti-cancer response in patients diagnosed with multiple cancers . Hurdles remain in optimizing antibody targeting and overcoming